Ignite Creation Date:
2025-12-25 @ 2:34 AM
Ignite Modification Date:
2025-12-26 @ 1:11 AM
Study NCT ID:
NCT02260934
Status:
COMPLETED
Last Update Posted:
2020-12-01
First Post:
2014-10-06
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Rituximab and Belimumab for Lupus Nephritis
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-07-09
Start Date Type:
ACTUAL
Primary Completion Date:
2018-03-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-02-08
Completion Date Type:
ACTUAL
First Submit Date:
2014-10-06
First Submit QC Date:
None
Study First Post Date:
2014-10-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-03-13
Results First Submit QC Date:
None
Results First Post Date:
2019-04-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-11-13
Last Update Post Date:
2020-12-01
Last Update Post Date Type:
ACTUAL